The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fenton Mary Kay since 2015.
This trader's CIK number is 1378589.
At the time of last reporting, Fenton Mary Kay was the Chief Financial Officer of Cullinan Therapeutics, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CGEM | 0 | $0 | 4,398 | $59,900 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ACHN | 0 | $0 | 56,625 | $648,480 | 56,625 | $98,175 |
1. Cullinan Therapeutics, Inc. (CGEM)
2. Achillion Pharmaceuticals Inc (ACHN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-20 | CGEM | Sale | 4,398 | 13.62 | 59,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-28 | ACHN | Sale | 43,500 | 10.08 | 438,480 |
| 2015-12-28 | ACHN | Option Ex | 43,500 | 1.05 | 45,675 |
| 2015-01-23 | ACHN | Sale | 13,125 | 16.00 | 210,000 |
| 2015-01-23 | ACHN | Option Ex | 13,125 | 4.00 | 52,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fenton Mary Kay (Chief Financial Officer of Cullinan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.